NeutroCheck
Pre-clinical- Indications
- Neutropenic sepsis
Company intelligence / Profile preview
52 North Health
Cambridge, England, United Kingdom52north.health ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Early results indicate that the NeutroCheck system enables rapid, at-home assessment of neutropenic sepsis risk in cancer patients, supporting earlier intervention and potentially reducing hospital admissions. The technology has been validated for usability and reliability in pilot settings but full pivotal trial or broad commercial launch data are not yet public.
- Therapeutic areas
- Oncology
- Modalities
- DeviceDigital platformArtificial intelligence (AI)-enabled technology
- Industry
- Physiological Monitoring
02
Drug pipeline
1 asset03
Partnerships
KHP Ventures (King’s Health Partners MedTech Innovations)Cedars-Sinai Intellectual Property Co. / Cedars-Sinai Medical Center [major academic medical center partnership/investment; not a traditional pharma partner but significant healthcare collaboration].
Beyond the preview
Go deeper on 52 North Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 52 North Health.